127 related articles for article (PubMed ID: 25762723)
21. UGT1A1 genotype and irinotecan therapy: general review and implementation in routine practice.
Etienne-Grimaldi MC; Boyer JC; Thomas F; Quaranta S; Picard N; Loriot MA; Narjoz C; Poncet D; Gagnieu MC; Ged C; Broly F; Le Morvan V; Bouquié R; Gaub MP; Philibert L; Ghiringhelli F; Le Guellec C; ;
Fundam Clin Pharmacol; 2015 Jun; 29(3):219-37. PubMed ID: 25817555
[TBL] [Abstract][Full Text] [Related]
22. PDZ Protein Regulation of G Protein-Coupled Receptor Trafficking and Signaling Pathways.
Dunn HA; Ferguson SS
Mol Pharmacol; 2015 Oct; 88(4):624-39. PubMed ID: 25808930
[TBL] [Abstract][Full Text] [Related]
23. Erratum to: A Stable Human-Cell System Overexpressing Cystic Fibrosis Transmembrane Conductance Regulator Recombinant Protein at the Cell Surface.
Hildebrandt E; Ding H; Mulky A; Dai Q; Aleksandrov AA; Bajrami B; Diego PA; Wu X; Ray M; Naren AP; Riordan JR; Yao X; DeLucas LJ; Urbatsch IL; Kappes JC
Mol Biotechnol; 2015 May; 57(5):406. PubMed ID: 25808031
[No Abstract] [Full Text] [Related]
24. Altered cGMP dynamics at the plasma membrane contribute to diarrhea in ulcerative colitis.
Arora K; Sinha C; Zhang W; Moon CS; Ren A; Yarlagadda S; Dostmann WR; Adebiyi A; Haberman Y; Denson LA; Wang X; Naren AP
Am J Pathol; 2015 Oct; 185(10):2790-804. PubMed ID: 26261085
[TBL] [Abstract][Full Text] [Related]
25. High-throughput RNAi screening of human kinases identifies predictors of clinical outcome in colorectal cancer patients treated with oxaliplatin.
Lin M; Zhang Y; Li A; Tang E; Peng J; Tang W; Zhang Y; Lu L; Xiao Y; Wei Q; Yin L; Li H
Oncotarget; 2015 Jun; 6(18):16774-85. PubMed ID: 25904054
[TBL] [Abstract][Full Text] [Related]
26. A randomized controlled pilot study to compare capecitabine-oxaliplatin with 5-FU-leucovorin as neoadjuvant concurrent chemoradiation in locally advanced adenocarcinoma of rectum.
Saha A; Ghosh SK; Roy C; Saha ML; Choudhury KB; Chatterjee K
J Cancer Res Ther; 2015; 11(1):88-93. PubMed ID: 25879343
[TBL] [Abstract][Full Text] [Related]
27. The overexpression of MRP4 is related to multidrug resistance in osteosarcoma cells.
He Z; Hu B; Tang L; Zheng S; Sun Y; Sheng Z; Yao Y; Lin F
J Cancer Res Ther; 2015; 11(1):18-23. PubMed ID: 25879330
[TBL] [Abstract][Full Text] [Related]
28. Sudden hearing loss due to oxaliplatin use in a patient with colon cancer.
Güvenç MG; Dizdar D; Dizdar SK; Okutur SK; Demir G
J Chemother; 2016 Aug; 28(4):341-2. PubMed ID: 25872564
[TBL] [Abstract][Full Text] [Related]
29. Global impact of KRAS mutation patterns in FOLFOX treated metastatic colorectal cancer.
Zocche DM; Ramirez C; Fontao FM; Costa LD; Redal MA
Front Genet; 2015; 6():116. PubMed ID: 25870609
[TBL] [Abstract][Full Text] [Related]
30. Tumor microenvironment in focus: LA-ICP-MS bioimaging of a preclinical tumor model upon treatment with platinum(IV)-based anticancer agents.
Theiner S; Kornauth C; Varbanov HP; Galanski M; Van Schoonhoven S; Heffeter P; Berger W; Egger AE; Keppler BK
Metallomics; 2015 Aug; 7(8):1256-64. PubMed ID: 25856224
[TBL] [Abstract][Full Text] [Related]
31. A meta analysis of cetuximab plus oxaliplatin based chemotherapy regimen for metastatic colorectal cancer.
Zhu YL; Lou J; Guo JY; Huang Z; Lv SW
Indian J Cancer; 2014 Mar; 51 Suppl 3():e113-6. PubMed ID: 25818736
[TBL] [Abstract][Full Text] [Related]
32. Clinical validation study of genetic markers for capecitabine efficacy in metastatic colorectal cancer patients.
van Huis-Tanja LH; Ewing E; van der Straaten RJ; Swen JJ; Baak-Pablo RF; Punt CJ; Gelderblom AJ; Guchelaar HJ
Pharmacogenet Genomics; 2015 Jun; 25(6):279-88. PubMed ID: 25815774
[TBL] [Abstract][Full Text] [Related]
33. Real-Life Report on Chemoembolization Using DEBIRI for Liver Metastases from Colorectal Cancer.
Stutz M; Mamo A; Valenti D; Hausvater A; Cabrera T; Metrakos P; Chaudhury P; Steacy G; Garoufalis E; Kavan P
Gastroenterol Res Pract; 2015; 2015():715102. PubMed ID: 25815009
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of TCH/TEC neoadjuvant chemotherapy for the treatment of HER-2-overexpressing breast cancer.
Chen W; He J; Song S; Wang M; Wu H; Wang X
Oncol Lett; 2015 Apr; 9(4):1922-1926. PubMed ID: 25789069
[TBL] [Abstract][Full Text] [Related]
35. Survivin and PSMA Loaded Dendritic Cell Vaccine for the Treatment of Prostate Cancer.
Xi HB; Wang GX; Fu B; Liu WP; Li Y
Biol Pharm Bull; 2015; 38(6):827-35. PubMed ID: 25787895
[TBL] [Abstract][Full Text] [Related]
36. ABCG2 and SLC1A5 functionally interact to rewire metabolism and confer a survival advantage to cancer cells under oxidative stress.
Shi J; Pabon K; Ding R; Scotto KW
J Biol Chem; 2024 Apr; 300(6):107299. PubMed ID: 38641063
[TBL] [Abstract][Full Text] [Related]
37. Structural basis of prostaglandin efflux by MRP4.
Pourmal S; Green E; Bajaj R; Chemmama IE; Knudsen GM; Gupta M; Sali A; Cheng Y; Craik CS; Kroetz DL; Stroud RM
Nat Struct Mol Biol; 2024 Apr; 31(4):621-632. PubMed ID: 38216659
[TBL] [Abstract][Full Text] [Related]
38. A personalized medicine approach to optimize care for a pediatric cystic fibrosis patient with atypical clinical symptoms.
Lee J; Husami A; Arora K; Zhang W; Kadri F; Yarlagadda S; Moon C; Mun KS; Zhang K; Huang Y; Liyanage P; Brewington J; Clancy JP; Shaikhkhalil A; Paul G; Naren AP
Pediatr Pulmonol; 2024 Jan; 59(1):229-232. PubMed ID: 37818777
[No Abstract] [Full Text] [Related]
39. Natural statin derivatives as potential therapy to reduce intestinal fluid loss in cholera.
Noitem R; Pongkorpsakol P; Changsen C; Sukpondma Y; Tansakul C; Rukachaisirikul V; Muanprasat C
PLoS Negl Trop Dis; 2022 Dec; 16(12):e0010989. PubMed ID: 36490300
[TBL] [Abstract][Full Text] [Related]
40. Patient personalized translational tools in cystic fibrosis to transform data from bench to bed-side and back.
Arora K; Yang F; Brewington J; McPhail G; Cortez AR; Sundaram N; Ramananda Y; Ogden H; Helmrath M; Clancy JP; Naren AP
Am J Physiol Gastrointest Liver Physiol; 2021 Jun; 320(6):G1123-G1130. PubMed ID: 33949881
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
